Director, Eu Qppv - Munich, Deutschland - Apellis Pharmaceuticals

Apellis Pharmaceuticals

Geprüftes Unternehmen

Munich, Deutschland

vor 2 Wochen

Geschrieben von:

Lena Wagner

beBee Recruiter

Beschreibung

Position:
Director, Qualified Person Responsible for Pharmacovigilance in the EU (EU QPPV)

Reports to:
Sr. Director, PV International

Location:
Munich, Germany

Position Summary:

The EU QPPV is responsible for the establishment and maintenance of the pharmacovigilance (PV) system and ensuring the system is compliant with EU regulations and other applicable local regulations and guidelines (e.g., EU GVP).

The EU QPPV will maintain a thorough understanding of the safety profiles of medicinal products in the Apellis portfolio under assessment or authorised in European countries.

The EU QPPV will act as a point of contact for EMA and other regulatory authorities, as needed, and will interact with the authorities regarding the safety of the products.

The EU QPPV will review, approve, and/or oversee the PSMF, RMPs, risk minimisation measures, PASS studies, global and local procedures, Safety Data Exchange Agreements, and audit reports.

The EU QPPV will participate in relevant meetings and committees and will have extensive cross-functional interactions across the organization.

The EU QPPV will lead and support the local EU PV representatives and Deputy EU QPPV and may serve as line manager.

The EU QPPV may act as regional/local PV responsible person in applicable European countries (e.g., Germany, UK).

Key Responsibilities Include:

Working with crossfunctional global and local teams to establish efficient and compliant safety data handling and postmarketing surveillance processes and procedures, focusing on the European region
Ensuring ongoing conduct of PV activities, including submission of PVrelated documents, is in accordance with regulations and guidelines
Maintaining awareness of safety concerns, marketing authorisation conditions and commitments, safetyrelated variations, and safety communications to patients and HCPs
Supporting and mentoring local PV representatives and ensuring local activities are aligned with regional and global standards
Supporting the due diligence and oversight of PV service providers and business partners
Assisting in safety review (signal assessment) and aggregate report generation
Maintaining the PSMF, ensuring regular review cycles
Partnering with Quality to lead inspection readiness, inspection/audit execution, and CAPA management
Acting as contact point for authorities for safetyrelated communications and coordinating safetyrelevant responses from various stakeholders
Overseeing risk management/minimisation activities and contributing to benefitrisk evaluations
Maintaining a comprehensive PV regulatory intelligence management process in Europe
Supporting the safety processes for clinical development in Europe
Maintaining Apellis data in Eudravigilance
Availability 24/7 as PV contact for regulatory authorities

Education, Registration & Certification:

Healthcare professional, physician highly preferred

Experience:

At least 10 years prior experience in PV, preferably in exUS markets
Experience interacting with EMA and other regulatory authorities
Experience with commercial and clinical lifecycle phases is desirable

Skills, Knowledge & Abilities:

Indepth knowledge of PV regulations and guidelines especially with regards to Europe
Demonstrated understanding of the safety database
Superior written and oral communication skills and the ability to influence and work effectively with different levels of management across departments
Highly motivated with the ability to be flexible in a fastpaced environment
Comfortable working independently with supervision

Ability to communicate in English and German, at business level

Benefits and Perks:

Apellis offers a great benefit package which includes: health insurance with full premium coverage, 401K with company match, paid time off (PTO), long

Company Background:

We are a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

We believe that this approach can result in broad inhibition of the principal pathways of the complement system and has the potential to effectively control a broad array of complement-dependent autoimmune and inflammatory diseases.

EEO Statement:

Other Duties:

Please note this job description is not designed to cover or contain a comprehensive listing of activities, duties or responsibilities that are required of the employee for this job.

Duties, responsibilities and activities may change at any time with or without notice.

**#LI-AC1